|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.82 SEK | -5.84% |
|
+31.61% | -12.30% |
| 23/06 | Citadel Back as Public Short Seller in Synact Pharma | FW |
| 19/06 | Edison Maintains Its Valuation for Synact Pharma After Trial Results | FW |
| Market Cap | 1.12B 115M 101M 93.13M 86.78M 164M 10.96B 167M 434M 5.38B 433M 423M 18.72B | P/E 2026 * |
-14.1x | P/E 2027 * | -27.7x |
|---|---|---|---|---|---|
| Enterprise Value | 1.1B 113M 99.6M 91.68M 85.43M 161M 10.79B 164M 427M 5.29B 426M 417M 18.42B | EV / Sales 2026 * |
7.95x | EV / Sales 2027 * | 54.1x |
| Free-Float |
70.28% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: SynAct Pharma AB
| 1 day | -8.50% | ||
| 1 week | +31.61% | ||
| Current month | -5.84% | ||
| 1 month | +31.26% | ||
| 3 months | +7.14% | ||
| 6 months | -11.71% | ||
| Current year | -12.30% |
| 1 week | 14.5 |  | 22.25 |
| 1 month | 7.05 | | 22.25 |
| Current year | 7.05 | | 24.4 |
| 1 year | 7.05 | | 25.3 |
| 3 years | 4.98 | | 124.6 |
| 5 years | 4.98 | | 146 |
| 10 years | 4.75 | | 146 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jeppe Øvlesen
CEO | Chief Executive Officer | 64 | 01/01/2014 |
Ann Kristin Led
DFI | Director of Finance/CFO | - | 01/03/2026 |
Kirsten Harting
CTO | Chief Tech/Sci/R&D Officer | - | 15/02/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Jeppe Øvlesen
BRD | Director/Board Member | 64 | 20/03/2024 |
Anders Kronborg
CHM | Chairman | 62 | 20/03/2024 |
Sten Scheibye
BRD | Director/Board Member | 74 | 20/03/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 10/03 | Buy | Chairman | 2,750 | 0.0052% | ||
| 09/03 | Buy | Executive/Senior Manager | 1,500 | 0.0028% | ||
| 09/03 | Quantass ApS
| Buy | Company | 7,900 | 0.0148% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.84% | +31.61% | +6.79% | -73.50% | 116M | |
| -1.26% | +6.56% | +53.44% | +158.01% | 1,070B | |
| -0.54% | +5.07% | +62.41% | +55.02% | 611B | |
| -0.57% | +6.63% | +31.83% | +85.52% | 445B | |
| -3.05% | +4.18% | +31.11% | +23.88% | 329B | |
| -1.74% | -0.40% | +33.19% | +33.55% | 290B | |
| -1.25% | +0.53% | +27.68% | +41.18% | 287B | |
| +2.99% | +4.00% | -26.09% | -40.14% | 213B | |
| -0.67% | +2.72% | +24.25% | +60.43% | 195B | |
| -0.17% | +0.97% | +13.11% | +64.73% | 157B | |
| Average | -1.35% | +8.39% | +25.77% | +40.87% | 359.63B | |
| Weighted average by Cap. | -0.80% | +6.67% | +38.51% | +78.82% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 139M 14.27M 12.53M 11.54M 10.75M 20.27M 1.36B 20.69M 53.76M 666M 53.6M 52.44M 2.32B | 21.15M 2.18M 1.91M 1.76M 1.64M 3.09M 207M 3.15M 8.19M 102M 8.17M 7.99M 353M |
| Net income | 52.18M 5.37M 4.71M 4.34M 4.04M 7.62M 510M 7.78M 20.22M 250M 20.15M 19.72M 872M | -26.04M -2.68M -2.35M -2.17M -2.02M -3.81M -255M -3.88M -10.09M -125M -10.06M -9.84M -435M |
| Net Debt | -17.48M -1.8M -1.58M -1.45M -1.35M -2.55M -171M -2.61M -6.77M -83.92M -6.75M -6.61M -292M | 24.86M 2.56M 2.25M 2.07M 1.93M 3.63M 243M 3.71M 9.63M 119M 9.6M 9.4M 415M |
Employees
8
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/07/26 | SEK 19.82 | -5.84% | 580,556 |
| 30/06/26 | SEK 21.05 | +14.40% | 823,897 |
| 29/06/26 | SEK 18.40 | +19.17% | 605,579 |
| 26/06/26 | SEK 15.44 | +0.92% | 189,143 |
| 25/06/26 | SEK 15.30 | +1.59% | 256,366 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SYNACT Stock
Select your edition
All financial news and data tailored to specific country editions
